Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study.
Abiden KaparSongsong XieZihao GuoYan NanYaling DuXi YinTao GongXiu GuYang ZhouWenli LuAimin YangZhaohui LuoJianghong DaiKailu WangShi ZhaoKai WangPublished in: Expert review of anti-infective therapy (2024)
Our findings indicated that Azvudine was associated with lower risk of all-cause death among hospitalized patients with Omicron BA.5 infection in a real-world setting. Further investigation is needed to explore the effectiveness of Azvudine against the PCC after discharge.